Pharmaceutical Membrane Filtration Market is Expected to Reach $19.6 billion | MarketsandMarkets™


Chicago, March 29, 2024 (GLOBE NEWSWIRE) — Pharmaceutical Membrane Filtration market in terms of revenue was estimated to be worth $10.6 billion in 2024 and is poised to reach $19.6 billion by 2029, growing at a CAGR of 13.1% from 2024 to 2029 according to a latest report published by MarketsandMarkets™. Stringent regulatory requirements, increasing number of R&D investments made by top pharmaceutical companies, increased preference of biopharmaceutical manufacturers and researchers for using single use technologies, are some factors responsible for the growth of the market. On the other hand, issues such as fouling of membrane, and the high capital investment required to set up new production facilities may limit the entry of small players into the market, thereby hampering the market growth.

Download an Illustrative overview:

Pharmaceutical Membrane Filtration Market Scope:


Report Coverage Details
Market Revenue in 2024 $10.6 billion
Estimated Value by 2029 $19.6 billion
Growth Rate Poised to grow at a CAGR of 13.1%
Market Size Available for 2021–2029
Forecast Period 2024–2029
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, Technique, Type, Application, And Scale Of Operation
Geographies Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunity Growth opportunities in emerging economies
Key Market Driver Increasing adoption of single-use technologies

Based on products, the pharmaceutical membrane filtration market is segmented into membrane filters, systems, and other products. Membrane filters segment dominated the market in 2023 owing to the high adoption and usage of membrane filters for various pharmaceutical applications. Additionally, owing to the high purchase frequency of these filters as compared to systems and other products contributes to its dominance.

Based on technique, the pharmaceutical membrane filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other techniques. Microfiltration offers various advantages over other techniques, including the use of microfiltration for the filtration of aqueous solutions. This technique is also used for the removal of natural and synthetic organic matter to reduce fouling potential. These factors are responsible for the segment’s highest share & growth rate in the global market.

Based on applications, the pharmaceutical membrane filtration market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. In 2023, final product processing was the largest and fastest-growing application segment of the global pharmaceutical membrane filtration market. Regulatory agencies such as the FDA (Food and Drug Administration) and EMA (European Medicines Agency) impose strict guidelines and standards on pharmaceutical manufacturers to ensure product safety, quality, and efficacy. Compliance with these regulations necessitates the implementation of robust filtration processes for final product processing, driving the demand for advanced membrane filtration technologies.

Based on type, the pharmaceutical membrane filtration market is segmented into sterile filtration and non-sterile filtration. The sterile filtration technique accounted for the largest market share of this market in 2023 owing to various factors such as the rapid growth of biologics, the need for sterile filtration during the liquid processing of biopharmaceuticals, and the benefits offered by sterile filtration as compared to non-sterile filtration.

Based on the scale of operation, the pharmaceutical membrane filtration market is segmented into manufacturing-scale, pilot-scale, and R&D-scale. The scale of operation in pharmaceutical filtration depends upon the size of the filtration production plant. The amount, limit, and volume to determine the scale vary for different industries. The manufacturing-scale segment is the largest and the fastest-growing segment in the pharmaceutical membrane filtration market in 2023. The growth in this segment can be attributed to the need to meet increasing demand for pharmaceuticals, the booming biopharmaceutical industry, and growing emerging markets.

Based on region, pharmaceutical membrane filtration market is segmented into six major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the pharmaceutical membrane filtration market. Europe held the second largest share followed by the Asia Pacific. The Asia Pacific market is expected to show the highest growth rate during the forecast period. Expansion in pharmaceutical manufacturing capacities, rising demand for specialty drugs, technological advancements & innovations in membrane designs are some of the factors contributing to the regional growth.

Buy a Pharmaceutical Membrane Filtration Industry Report (502 Pages PDF with Insightful Charts, Tables, and Figures):

Pharmaceutical Membrane Filtration market major players covered in the report, such as:

  • Merck KGaA (Germany)
  • Danaher Corporation (US)
  • Sartorius AG (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • 3M Company (US)
  • Parker Hannifin Corporation (US)
  • Repligen Corporation (US)
  • Asahi Kasei Corporation (Japan)
  • Eaton Corporation plc (Ireland)
  • GEA Group (Germany)
  • Corning Incorporated (US)
  • Alfa Laval Corporate AB (Sweden)
  • Donaldson Company, Inc. (US)
  • Saint-Gobain (France)
  • MANN+HUMMEL International GmbH & Co. KG (Germany)
  • Meissner Filtration Products, Inc. (US)
  • Cole-Parmer Instrument Company, LLC (US)
  • Applexion (France)
  • Cantel Medical Corp. (US)
  • W. L. Gore & Associates Inc. (US)
  • Membrane Solutions (US)
  • Amazon Filters Ltd. (UK)
  • Toyo Roshi Kaisha, Ltd. (Japan)
  • Porvair plc (UK)
  • Sterlitech Corporation (US)
  • Synder Filtration, Inc. (US)
  • Graver Technologies, LLC (US)
  • Koch Membrane Systems, Inc. (US)
  • Nupore Filtration Systems (India)
  • Cobetter Filtration Equipment Co., Ltd. (China)
  • and Among Others

Request for FREE Sample Pages:

This report categorizes the pharmaceutical membrane filtration market into the following segments:

Pharmaceutical membrane filtration market, by Product

  • Membrane Filters
    • Polyethersulfone (PES) Membrane Filters
    • Polyvinylidene difluoride (PVDF) Membrane Filters
    • Nylon Membrane Filters
    • Polytetrafluoroethylene (PTFE) Membrane Filters
    • Mixed Cellulose Ester & Cellulose Acetate (MCE & CA) Membrane Filters
    • Polycarbonate Track-Etched (PCTE) Membrane Filters
    • Other Membrane Filters (PP, PC, CN, Gelatin, PETE, RC)
  • Systems
    • Single-Use Systems
    • Reusable Systems
  • Other Products
    • Membrane Filtration Assemblies
    • Accessories

Pharmaceutical membrane filtration market, by Technique

  • Microfiltration
  • Ultrafiltration
  • Nanofiltration
  • Other Techniques

Pharmaceutical membrane filtration market, by Application

  • Final Product processing
    • Active Pharmaceutical Ingredients (APIs) Filtration
    • Protein Purification
    • Vaccines and Antibody Processing
    • Formulation and Filling Solutions
    • Viral Clearance
  • Raw Material Filtration
    • Media and Buffer Filtration
    • Pre-filtration
    • Bioburden Testing
  • Cell Separation
  • Water Purification
  • Air Purification

Pharmaceutical membrane filtration market, by Type

  • Sterile Filtration
  • Non-Sterile Filtration

Pharmaceutical membrane filtration market, by Scale of Operation

  • Manufacturing-Scale Operation
  • Pilot-Scale Operation
  • R&D-Scale Operation

Pharmaceutical membrane filtration market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • RoLATAM
  • Middle East
    • GCC
      • Saudi Arabia
      • UAE
      • Rest of GCC
    • Rest of Middle East
  • Africa

Get 10% Free Customization on this Report:

Key Market Stakeholders:

  • Filter Manufacturers, Vendors, and Distributors
  • Academic and Government Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Life Science Companies
  • Venture Capitalists and Investors
  • Government Organizations
  • Private Research Firms
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)

Report Objectives:

  • To define, describe, and forecast the global pharmaceutical membrane filtration market based on the product, technique, type, application, scale of operation and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities and challenges)
  • To strategically analyze micro-markets with respect to individual growth trends, future prospects, and contributions to the overall pharmaceutical membrane filtration market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East and Africa
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the pharmaceutical membrane filtration market.

Related Reports:

Pharmaceutical Filtration Market

Sterile Filtration Market

Hollow Fiber Filtration Market

Depth Filtration Market

Laboratory Filtration Market

Research Insights:

Content Source:

CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: [email protected]

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.